Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2020
Oct. 31, 2019
Income Statement [Abstract]    
Revenue
Expenses:    
Research and development 9,799,361 5,420,159
General and administrative 3,240,732 4,418,217
Loss from operations (13,040,093) (9,838,376)
Other (expense) income, net (623) 82,387
Interest expense (6,134) (992)
Foreign currency exchange loss, net (176,917) (3,503)
Loss before income taxes (13,223,767) (9,760,484)
Income tax expense 1,500
Net loss $ (13,225,267) $ (9,760,484)
Basic and diluted net loss per common share $ (0.49) $ (0.92)
Weighted average shares used in computing basic and diluted net loss per common share 26,771,176 10,648,540